Lim, Seng Gee http://orcid.org/0000-0003-0994-4932
Baumert, Thomas F. http://orcid.org/0000-0002-8864-2168
Boni, Carolina
Gane, Ed
Levrero, Massimo
Lok, Anna S.
Maini, Mala K. http://orcid.org/0000-0001-6384-1462
Terrault, Norah A.
Zoulim, Fabien http://orcid.org/0000-0002-2245-0083
Article History
Accepted: 24 November 2022
First Online: 11 January 2023
Competing interests
: S.G.L. is on the advisory board for Gilead Sciences, Abbott, Roche, Janssen, GlaxoSmithKline (GSK), Grifols, Arbutus, Assembly. He is on the speakers’ bureau for Gilead Sciences, Abbott GSK, Roche and Janssen, and receives educational/research funding from Abbott, Merck Sharpe and Dohme (MSD), Gilead Sciences. T.F.B. is a founder, shareholder and adviser for Alentis Therapeutics. He receives Institutional grant support from Aligos, Janssen, Alentis, Roche. C.B. is a consultant and on the advisory board for Gilead Sciences. E.G. is on the advisory board for AbbVie, Aligos Therapeutics, Arbutus Biopharma, Arrowhead Pharmaceuticals, Assembly Biosciences, Avalia Immunotherapies, BlueJay Therapeutics, Brii Biosciences, Clear B Therapeutics, Dicerna Pharmaceuticals, Enanta Pharmaceuticals, Finch Therapeutics, Gilead Sciences, GSK, Immunocore, Janssen, Roche, Silverback, Vaccitech, Benatorx, Virion Therapeutics and Vir Biotechnology. He is on the speakers’ bureau for Gilead Sciences, AbbVie, Abbott Diagnostics, Intellia and Roche. M.L. receives educational/research funding from AbbVie, Gilead, MSD, Roche, Bayer, Ipsen. A.L. receives research grants from Gilead, Target. M.K.M. is on the advisory board for Gilead Sciences, Roche, GSK, Vir Biotechnology and receives research funding from Gilead Sciences. N.T. is on the consulting/advisory boards for Moderna; she receives Institutional grant support from Gilead Sciences, GSK, Roche–Genentech and Helio Health. F.Z. acts as a consultant for Aligos, Antios, Arbutus, Assembly, Enanta, Gilead, GSK, Roche, Viravaxx, Zhimeng; he receives research grants from Assembly, Beam, Janssen, Viravaxx.